Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?

[1]  S. Gabriel,et al.  Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. , 2002, The Journal of rheumatology.

[2]  E. Topol,et al.  Risk of cardiovascular events associated with selective COX-2 inhibitors. , 2001, JAMA.

[3]  L. Crofford,et al.  Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary Arteries , 2001, Circulation.

[4]  Peter Libby,et al.  Current Concepts of the Pathogenesis of the Acute Coronary Syndromes , 2001, Circulation.

[5]  M. Woodward,et al.  Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. , 2001, Rheumatology.

[6]  M. Ward,et al.  Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs? , 2001, Arthritis and rheumatism.

[7]  A. Familian,et al.  Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein. , 2001, Arthritis and rheumatism.

[8]  S. Grundy,et al.  Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels , 2001, Circulation.

[9]  P. Mcgeer,et al.  Generation of C-reactive protein and complement components in atherosclerotic plaques. , 2001, The American journal of pathology.

[10]  R. Moots,et al.  Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA , 2001, Annals of the rheumatic diseases.

[11]  P. Wilson,et al.  Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. , 2001, The American journal of clinical nutrition.

[12]  A. Silman,et al.  The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. , 2001, Arthritis and rheumatism.

[13]  Xinghua Zhou,et al.  Transfer of CD4+ T Cells Aggravates Atherosclerosis in Immunodeficient Apolipoprotein E Knockout Mice , 2000, Circulation.

[14]  M. Prevoo,et al.  No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset , 2000, Annals of the rheumatic diseases.

[15]  B. Ostrov,et al.  Clinical Images: Hip joint remodeling in systemic-onset juvenile rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[16]  R Day,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[17]  James T. Willerson,et al.  Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells , 2000, Circulation.

[18]  Cleland Lg,et al.  Fish oil and rheumatoid arthritis: antiinflammatory and collateral health benefits. , 2000, The Journal of rheumatology.

[19]  N. Olsen,et al.  Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. , 2000, Arthritis and rheumatism.

[20]  J. Danesh,et al.  Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies , 2000, Circulation.

[21]  D. Gladman,et al.  Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus. , 2000, The Journal of rheumatology.

[22]  J. Danesh,et al.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.

[23]  R. Frye,et al.  Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. , 2000, Circulation.

[24]  B. Dijkmans,et al.  Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity , 2000, The Lancet.

[25]  P. Ridker,et al.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.

[26]  J. Platt,et al.  Endothelial cell activation by pore-forming structures: pivotal role for interleukin-1alpha. , 2000, Circulation.

[27]  G. Hansson,et al.  Molecular Medicine © 2000 The Picower Institute Press Induction of Neonatal Tolerance to Oxidized Lipoprotein Reduces Atherosclerosis In ApoE Knockout Mice , 2000 .

[28]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[29]  F. Wolfe,et al.  The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. , 2000, The Journal of rheumatology.

[30]  S. Nakae,et al.  Development of Chronic Inflammatory Arthropathy Resembling Rheumatoid Arthritis in Interleukin 1 Receptor Antagonist–Deficient Mice , 2000, The Journal of experimental medicine.

[31]  G. Duff,et al.  Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene , 2000, The Journal of experimental medicine.

[32]  S. Urieli-Shoval,et al.  Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states , 2000, Current opinion in hematology.

[33]  R. Rau,et al.  Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[34]  D. Symmons,et al.  Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. , 2000, Scandinavian journal of rheumatology.

[35]  S. R. Dahlqvist,et al.  Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year followup study. , 2000, The Journal of rheumatology.

[36]  Y. Lee,et al.  Lipoprotein(a) and Lipids in Relation to Inflammation in Rheumatoid Arthritis , 2000, Clinical Rheumatology.

[37]  Y. H. Lee,et al.  Serum Creatine Kinase in Patients with Rheumatic Diseases , 2000, Clinical Rheumatology.

[38]  C. Weyand,et al.  The role of T cells in rheumatoid arthritis. , 2000, Archivum immunologiae et therapiae experimentalis.

[39]  S. Gabriel,et al.  Mortality in rheumatoid arthritis: have we made an impact in 4 decades? , 1999, The Journal of rheumatology.

[40]  S. Rantapää-Dahlqvist,et al.  Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. , 1999, The Journal of rheumatology.

[41]  W M O'Fallon,et al.  Comorbidity in arthritis. , 1999, The Journal of rheumatology.

[42]  M. Boissier,et al.  Mortality in rheumatoid arthritis. , 1999, Revue du rhumatisme.

[43]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[44]  Roberto Marchioli,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .

[45]  C. Suh,et al.  Lipid profiles in untreated patients with rheumatoid arthritis. , 1999, The Journal of rheumatology.

[46]  J. Manson,et al.  A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. , 1999, Arthritis and rheumatism.

[47]  P. Ridker,et al.  A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study. , 1999, Journal of the American College of Cardiology.

[48]  H. Aoshima,et al.  Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[49]  E. Martı́n-Mola,et al.  Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women. , 1999, Clinical biochemistry.

[50]  H. Blom,et al.  Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis , 1999, Annals of the rheumatic diseases.

[51]  A. Döring,et al.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.

[52]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[53]  G. FitzGerald,et al.  Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[54]  E. Lindqvist,et al.  Mortality in rheumatoid arthritis patients with disease onset in the 1980s , 1999, Annals of the rheumatic diseases.

[55]  P. Hannonen,et al.  Mortality in early "sawtooth" treated rheumatoid arthritis patients during the first 8-14 years. , 1999, Scandinavian journal of rheumatology.

[56]  T. Kvien,et al.  Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. , 1999, The Journal of rheumatology.

[57]  L. Weinehall,et al.  High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. , 1998, Circulation.

[58]  Functional status predicts mortality in a community based rheumatoid arthritis population. , 1998, The Journal of rheumatology.

[59]  S. Kaveri,et al.  Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. , 1998, The Journal of clinical investigation.

[60]  P. Ridker,et al.  Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. , 1998, Circulation.

[61]  P. Libby,et al.  Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.

[62]  D. Symmons,et al.  Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. , 1998, The Journal of rheumatology.

[63]  C. Friman,et al.  Serum homocysteine and methylmalonic acid in patients with rheumatoid arthritis and cobalaminopenia. , 1998, The Journal of rheumatology.

[64]  H. Blom,et al.  Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials , 1998, BMJ.

[65]  G. Alarcón,et al.  Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. , 1998, The Journal of rheumatology.

[66]  P. Ridker,et al.  Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men , 1998, The Lancet.

[67]  A. Herrick,et al.  Lack of certainty on the diagnosis of acute intermittent porphyria: comment on the concise communication by Cohen et al. , 1998, Arthritis and rheumatism.

[68]  L. Berglund,et al.  Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[69]  A. Silman,et al.  Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. , 1997, Arthritis and rheumatism.

[70]  L. Cleland,et al.  Dietary n-3 fatty acids and therapy for rheumatoid arthritis. , 1997, Seminars in arthritis and rheumatism.

[71]  G. Hughes,et al.  Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome. , 1997, British journal of rheumatology.

[72]  J. Cerhan,et al.  Cigarette smoking and rheumatoid arthritis severity , 1997, Annals of the rheumatic diseases.

[73]  R. Madhok,et al.  Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis , 1997, Annals of the rheumatic diseases.

[74]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[75]  I. Rosenberg,et al.  Abnormal homocysteine metabolism in rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[76]  S. R. Dahlqvist,et al.  Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. , 1997, The Journal of rheumatology.

[77]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[78]  I. Rosenberg,et al.  Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus , 1996, The Lancet.

[79]  A. Silman,et al.  Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. , 1996, Arthritis and rheumatism.

[80]  M. Petri.  Biochemical characterization of ADP-ribose polymer metabolism in SLE. , 1996 .

[81]  K. Aho,et al.  Mortality in rheumatoid arthritis. , 1995, Seminars in arthritis and rheumatism.

[82]  F. Wolfe,et al.  The mortality of rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[83]  L. Tenkanen,et al.  Antibody against oxidized low-density lipoprotein predicting myocardial infarction. , 1994, Archives of internal medicine.

[84]  Bruce Kinosian,et al.  Cholesterol and Coronary Heart Disease: Predicting Risks by Levels and Ratios , 1994, Annals of Internal Medicine.

[85]  T. Koepsell,et al.  Smoking, Obesity, Alcohol Consumption, and the Risk of Rheumatoid Arthritis , 1994, Epidemiology.

[86]  G. Dahlén.  Lp(a) lipoprotein in cardiovascular disease. , 1994, Atherosclerosis.

[87]  K. Rentsch,et al.  Relation of cyclosporine blood levels to adverse effects on lipoproteins. , 1994, Transplantation.

[88]  S. Urieli-Shoval,et al.  Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[89]  L. Magder,et al.  Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. , 1994, The American journal of medicine.

[90]  A. Reunanen,et al.  Smoking and risk of rheumatoid arthritis. , 1993, The Journal of rheumatology.

[91]  S. Pillemer,et al.  Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. , 1993, Arthritis and rheumatism.

[92]  D. Wallace.  Plasmapheresis in Lupus , 1993, Lupus.

[93]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[94]  M. Jauhiainen,et al.  Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus , 1993, The Lancet.

[95]  F. Shojaee-Moradie,et al.  Effects of chloroquine on the dyslipidemia of non-insulin-dependent diabetes mellitus. , 1993, Metabolism: clinical and experimental.

[96]  D. Wallace,et al.  The Relevance of Antimalarial Therapy with Regard to Thrombosis, Hypercholesterolemia and Cytokines in SLE , 1993, Lupus.

[97]  P. Davis,et al.  The Clinical Significance of Autoantibody Profiles in Patients with Systemic Lupus Erythematosus , 1993, Lupus.

[98]  B. Myones,et al.  Dyslipoproteinemia in the course of active rheumatoid arthritis. , 1992, Seminars in arthritis and rheumatism.

[99]  T. Pincus,et al.  Rheumatology function tests: grip strength, walking time, button test and questionnaires document and predict longterm morbidity and mortality in rheumatoid arthritis. , 1992, The Journal of rheumatology.

[100]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[101]  J. Fries,et al.  Mortality predictors among 263 patients with rheumatoid arthritis. , 1991, The Journal of rheumatology.

[102]  G. Paolisso,et al.  Evidence for peripheral impaired glucose handling in patients with connective tissue diseases. , 1991, Metabolism: clinical and experimental.

[103]  S. Rantapää-Dahlqvist,et al.  Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. , 1991, Annals of the rheumatic diseases.

[104]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[105]  H. Isomäki,et al.  Intramuscular gold therapy is associated with long survival in patients with rheumatoid arthritis. , 1991, The Journal of rheumatology.

[106]  J P Vandenbroucke,et al.  Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. , 1990, Annals of the rheumatic diseases.

[107]  T. Tuomi,et al.  Smoking, lung function, and rheumatoid factors. , 1990, Annals of the rheumatic diseases.

[108]  D. Wallace,et al.  Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids. , 1990, The American journal of medicine.

[109]  W. Willett,et al.  Reproductive Factors, Smoking, and the Risk for Rheumatoid Arthritis , 1990, Epidemiology.

[110]  A. Silman,et al.  Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. , 1990, Annals of the rheumatic diseases.

[111]  A. Walker,et al.  Use of Replacement Estrogens and the Risk of Myocardial Infarction , 1990, Epidemiology.

[112]  J. Pearson,et al.  von Willebrand factor is an acute phase reactant in man. , 1989, Thrombosis research.

[113]  P. Venables,et al.  Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. , 1989, Annals of the rheumatic diseases.

[114]  J. Lakatos,et al.  Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis. , 1988, Clinical biochemistry.

[115]  H. Lithell,et al.  Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment. , 1987, Archives of internal medicine.

[116]  H. Lithell,et al.  Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. , 1987, Archives of internal medicine.

[117]  L. Wide,et al.  Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones. , 1987, Metabolism: clinical and experimental.

[118]  T. Pincus,et al.  Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity. , 1986, The Journal of rheumatology.

[119]  M. Gimbrone,et al.  Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. , 1986, The Journal of clinical investigation.

[120]  J. Fries,et al.  Survival, prognosis, and causes of death in rheumatoid arthritis. , 1986, Arthritis and rheumatism.

[121]  M. Laakso,et al.  Death certificate and mortality in rheumatoid arthritis. , 1986, Scandinavian journal of rheumatology.

[122]  M. Laakso,et al.  Ten year mortality and causes of death in patients with rheumatoid arthritis. , 1985, British medical journal.

[123]  T. Pincus,et al.  Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. , 1984, Arthritis and rheumatism.

[124]  D. Symmons,et al.  Cause of death in rheumatoid arthritis. , 1984, British journal of rheumatology.

[125]  P. Allebeck.  Increased Mortality in Rheumatoid Arthritis: The Use of a Medical Information System for Assessment of Death Risks , 1982 .

[126]  P. Allebeck,et al.  Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate. Eleven-year follow-up of an epidemiological study. , 1981, Scandinavian journal of rheumatology.

[127]  R. Hanka,et al.  Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. , 1980, Annals of the rheumatic diseases.

[128]  A. Linos,et al.  The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. , 1980, American journal of epidemiology.

[129]  R. Monson,et al.  Mortality among arthritics. , 1976, Journal of chronic diseases.

[130]  H. Isomäki,et al.  Causes of death in autopsied RA patients. , 1976, Scandinavian journal of rheumatology.

[131]  H. G. Kelly,et al.  Survivorship and death in rheumatoid arthritis. , 1970, Arthritis and rheumatism.

[132]  S. Cobb,et al.  Length of life and cause of death in rheumatoid arthritis. , 1953, The New England journal of medicine.